← Back to headlines
Allogene Therapeutics, Inc. Recommended as Top Penny Stock on CAR T-Cell Portfolio
Allogene Therapeutics, Inc. is suggested as a top penny stock to buy, attributed to its robust portfolio of CAR T-Cell therapies.
7 Jun, 17:57 — 7 Jun, 17:57
Sources
Showing 1 of 1 sources
